Market Closed -
Other stock markets
|
Pre-market 07:06:56 am | |||
166.4 USD | +1.27% | 166.7 | +0.16% |
May. 17 | Cantor Fitzgerald Initiates AbbVie at Overweight Rating With $200 Price Target | MT |
May. 17 | ANALYST RECOMMENDATIONS : Walmart, Netflix, Abbvie, Delta... |
Evolution of the average Target Price on AbbVie Inc.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering AbbVie Inc.
Cantor Fitzgerald | |
Daiwa Securities | |
BMO Capital | |
Mizuho Securities | |
Barclays | |
Deutsche Bank Securities | |
UBS | |
Truist Securities | |
Piper Sandler | |
Morningstar | |
Wells Fargo Securities | |
Goldman Sachs | |
Raymond James | |
William Blair & Co. | |
BofA Securities | |
HSBC | |
Morgan Stanley | |
Guggenheim | |
Argus | |
Wolfe Research | |
Atlantic Equities | |
SVB Securities LLC | |
Credit Suisse | |
Societe Generale | |
Berenberg Bank | |
JPMorgan Chase | |
Cowen | |
Redburn | |
SVB Leerink | |
RBC Capital Markets |
EPS Revisions
- Stock Market
- Equities
- ABBV Stock
- Consensus AbbVie Inc.